Skip to main content
Premium Trial:

Request an Annual Quote

Courtagen, Scienion Ink Protein Biochip Deal

NEW YORK (GenomeWeb News) – Scienion US said today that array firm Courtagen Life Sciences will use Scienion's sciFlexArrayer technology to produce biochips for use with its Avantra Q400 Biomarker Workstation.

Courtagen will use the company's sciFlexArrayer S11 instrument to produce biochips for automated multiplex immunoassays for research and clinical use.

Courtagen was launched as Avantra Biosciences in December 2009 from the assets of defunct biomarker firm Decision Biomarkers. The company launched the Q400 as a research-only device in January 2011 along with its Angio Qx BioChip immunoassay for the study of tumor vascularization.

Last month, the company announced that it had submitted a pre-investigational device exemption information package to the US Food and Drug Administration for its Avantra Q400 Biomarker Workstation and its QPDX BioChip for the measurement of C-reactive protein.

"We have been looking for a reliable solution for the reproducible high throughput production of spotted arrays for our QPDx BioChips," Kate Sheldon, director of product development at Courtagen, said in a statement. "The Scienion sciFlexArrayer S11 is able to consistently produce high quality arrays that meet our needs and has the capacity to meet demand as our business grows."

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.